Congo vs Mus: Previously treated cases tested for RR-/MDR-TB (%)
Congo
100.0%
in 2024
Mus
100.0%
in 2022
Congo rank
1st
Mus rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Congo
- Mus
How they compare
Congo currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2013 it was Mus ahead.
Congo ranks 1st and Mus ranks 1st of 180 countries.
Mus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.2% | 93.3% | 16.2% | Mus |
| 2020s | 49.7% | 100.0% | 50.3% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Mus?
- Congo, at 100.0% against 100.0% in Mus as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Mus?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Mus?
- 9 years are reported by both, from 2013 to 2022.
- How do Congo and Mus rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Mus ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.